chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Site: Bruising at Injection Site-Medium, Site: Itching at Injection Site-Severe, Site: Pain at Injection Site-Severe, Site: Redness at Injection Site-Severe, Site: Swelling at Injection Site-Severe, Systemic: Body Aches Generalized-Medium, Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: right sided chest pain purple rash ans soreness on right ankle nerve pain over all body all subsided for the most part-Medium, Systemic: Numbness (specify: facial area, extremities)-Severe, Systemic: Tingling (specify: facial area, extemities)-Medium
abnormal TSH on routine lab screening on 2/1/2021. TSH level was high at 4.376 while free T4 level was normal, indicating subclinical hypothyroidism. Previous routine lab screenings done in July 2020 showed normal values for TSH & free T4  Will recheck thyroid labwork in 6 weeks, scheduled for 3/16/21
Extensive teeth chatter and some lose of control of my jaw. I had extreme chills and my bones  and body ached all over...worse than when I got covid sickness last October.
I had problems with my lymph nodes swelling; I have not been well since I had it.; I am having a lot of problems with my left lymph nodes under my breast.,They are really sore and painful/gradually getting worse.; I am exhausted all the time; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (I had problems with my lymph nodes swelling), MALAISE (I have not been well since I had it.), LYMPH NODE PAIN (I am having a lot of problems with my left lymph nodes under my breast.,They are really sore and painful/gradually getting worse.) and FATIGUE (I am exhausted all the time) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026A21A and 008B21-2A) for COVID-19 vaccination.     Concurrent medical conditions included Depression and GERD. Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) for Depression, OMEPRAZOLE for GERD.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (I had problems with my lymph nodes swelling), MALAISE (I have not been well since I had it.), LYMPH NODE PAIN (I am having a lot of problems with my left lymph nodes under my breast.,They are really sore and painful/gradually getting worse.) and FATIGUE (I am exhausted all the time). The patient was treated with PARACETAMOL (TYLENOL) at a dose of occasionally. At the time of the report, LYMPHADENOPATHY (I had problems with my lymph nodes swelling), MALAISE (I have not been well since I had it.), LYMPH NODE PAIN (I am having a lot of problems with my left lymph nodes under my breast.,They are really sore and painful/gradually getting worse.) and FATIGUE (I am exhausted all the time) outcome was unknown.            The patient had both the vaccines and had problems with their lymph nodes swelling. The patient stated it went down after a while, but the patient was having a lot of problems with their left lymph nodes under their breast. They were really sore and painful. The patient reported that they never had this problem before and had bad reactions to both doses. The patient also reported that most recently about 2 weeks before when this started and it went away after the initial couple of weeks, but it started back two weeks ago and was gradually getting worse.   Reportedly, the patient has not been well since vaccine and felt exhausted all the time.  The patient took concomitant medications Lexapro for depression x 8 years and Omeprazole 40 mg for stomach issues (GERD) x 6 years   This case was linked to MOD-2021-211466 (Patient Link).
G9 administered to 70 year old pt by accident; This spontaneous report was received from a physician referring to a 70 years old patient of unknown gender. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not provided.      On 14-SEP-2020, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose, frequency, route, lot# and expiration date were not reported) for prophylaxis by mistake (product administered to patient of inappropriate age).
Crying on and off; Headache since 3 in the morning; Body temperature was 99 to 100 in the morning; Chills; A sore arm, leg in pain; Body felt funny; Tired legs; Sweat; Feeling hot and cold; Tingly; Flu like symptoms; Back pain; Butt pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A sore arm, leg in pain), FEELING ABNORMAL (Body felt funny), LIMB DISCOMFORT (Tired legs), HYPERHIDROSIS (Sweat) and FEELING OF BODY TEMPERATURE CHANGE (Feeling hot and cold) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A and 027B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Migraine. Concomitant products included BOTULINUM TOXIN TYPE A (BOTOX) from 01-May-2021 to an unknown date for Migraine.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-May-2021, the patient experienced PAIN IN EXTREMITY (A sore arm, leg in pain), FEELING ABNORMAL (Body felt funny), LIMB DISCOMFORT (Tired legs), HYPERHIDROSIS (Sweat), FEELING OF BODY TEMPERATURE CHANGE (Feeling hot and cold), INFLUENZA LIKE ILLNESS (Flu like symptoms), BACK PAIN (Back pain), MUSCULOSKELETAL PAIN (Butt pain) and CHILLS (Chills). 14-May-2021, the patient experienced PARAESTHESIA (Tingly). On 15-May-2021, the patient experienced CRYING (Crying on and off), HEADACHE (Headache since 3 in the morning) and PYREXIA (Body temperature was 99 to 100 in the morning). The patient was treated with IBUPROFEN on 16-Apr-2021 for Adverse event, at a dose of 800 milligram. At the time of the report, PAIN IN EXTREMITY (A sore arm, leg in pain), FEELING ABNORMAL (Body felt funny), LIMB DISCOMFORT (Tired legs), HYPERHIDROSIS (Sweat), FEELING OF BODY TEMPERATURE CHANGE (Feeling hot and cold), PARAESTHESIA (Tingly), INFLUENZA LIKE ILLNESS (Flu like symptoms), BACK PAIN (Back pain), MUSCULOSKELETAL PAIN (Butt pain), CRYING (Crying on and off), CHILLS (Chills), HEADACHE (Headache since 3 in the morning) and PYREXIA (Body temperature was 99 to 100 in the morning) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-May-2021, Body temperature: 99-100 Inconclusive.         This case was linked to US-MODERNATX, INC.-MOD-2021-132734, US-MODERNATX, INC.-MOD-2021-132945 (E2B Linked Report). This case was linked to MOD-2021-133031 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-132734: US-MODERNATX, INC.-MOD-2021-132945:
Narrative:  Patient presented to ER with progressive shortness of breath, fever, myalgias, change in taste, diarrhea, and positive COVID-19 test. He was symptomatic for the past 4 days or prior to ER presentation. Had a positive test at outside facility the day prior. Home oxygen saturation via self-monitoring and was low in the 80s so came to the ER for further evaluation. Progressive shortness of breath. Vaccinated for COVID with 2 doses earlier in the year. Dx with COVID PNA and admitted. PMH of CKD, HTN, HLD. Treated with dexamethasone (dexamethasone 6 mg tab 10/19-10/20), remdesivir (200mg IV once 10/19), supplemental O2, albuterol/ipratropium inhalers, zinc, vit C, vit D, and PRN benzonatate, guaifenesin, codeine/guaifenesin, and throat lozenges. Transferred to MICU 10/19/21. Treated with barictinib (2mg doses 10/19-10/20). Intubated 10/20. Complications included septic shock, pre-renal AKI, and hypocalcemia. Patient died 10/21/21.
Headache, muscle and joint pain, particularly lower back. skin hypersensitivity, particularly palms and bottom of feet.
Raynaud's symptoms in my lt. distal 2nd phalange and my rt. 3rd distal phalange.; This is a spontaneous report from a contactable other hcp (Patient himself). A 60-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: EK 9231), via an unspecified route of administration, administered in Arm Left on 19Jan2021 08:30 (Age at time of vaccination 60-years-old) as UNKNOWN, SINGLE DOSE for covid-19 immunization. Medical history included, drug hypersensitivity from an unknown date and unknown if ongoing known allergies: Tequin or any Quinolone antibiotic. Concomitant medication(s) included (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) patient received within 2 weeks of vaccination for an unspecified indication, start and stop date were not reported. Facility where the most recent COVID-19 vaccine was administered: Hospital. patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment received for AE. On 19Jan2021 14:30 The patient experienced raynaud's symptoms in my lt. distal 2nd phalange and my rt. 3rd distal phalange. No Seriousness criteria reported. The outcome of event was not recovered.  Follow-up attempts are completed. No further information is expected.
Tingling in right arm where vaccine was given. Hot at the site in her "R" hand. Still tingling 45 minutes after. Following up with Telemedicine.
Three days of chills, fever, muscle aches, joint aches, headache, extreme fatigue
5/2/2003 Began to "feel bad"-allergies and diarrhea. 5/5/2003 Saw PMD-treated with antibiotic-Z-pack with diagnosis of upper respiratory infection.
Approximately 48 hours after administration of Shingrix and Havrix, a rash developed on upper back (bilateral).  The rash was associated with itching, no pain, no tingling.  Rash then went down back and progressed to hand (palms), soles of feet.  The rash would last about 24 to 48 hours and then disappear.  New rashes continue to appear and disappear in different parts of body.  Myalgias reported.  The patient has consulted two MDs and hydrocortisone was recommended.  At current time, patient is still having issues.  Patient also has ALS and taking riluzole as part of a study. Unknown if this occurence is related to vaccines, riluzole, or combination of both.
This spontaneous case reported by a consumer, describes the occurrence of tremors, pruritus (face very itchy), erythema (face red), hot flush (face flushed) and chills in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, after the mRNA-1273 (Moderna COVID-19 vaccine), patient experienced tremors, pruritus (face very itchy), erythema (face red), hot flush (face flushed) and chills. The patient treated with hydrocortisone at an unspecified dose and frequency. At the time of the report, tremors, pruritus (face very itchy), erythema (face red), hot flush (face flushed) and chills outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The patient applied ice on her face. No concomitant medications reported.
complaints of nausea vomiting fever arthralgias myalgias for 1 day; + Covd in ED; CXR clear; no sepsis; not a candidate for remdesivir or steroids; remained on room air during hospitalization; tx: maxipime, vancomycin, Vit C, Lovenox, Zinc
pt recvd vax afternoon of 26SEP95;fine rest of day given Motrin;slept all noc;went to daycare fell asleep 9-10AM & could not be aroused for 8-9hrs; pale, unresponsive;did not seek medical attention @ the time
pt recv vax  in AM & late evening pt started w/mild h/a;pt awaken @ 4AM w/severe h/a & neck pain that got gradually worse during day;spinal tap done to f/o meningitis;dismissed from ER @ 7PM w/med for h/a;pt stated arm hurt;
p/vax pt to clinic w/generalized rash to face, extremities & trunk of body;pt developing urticaria;pt c/o itching & tightness in throat;had urticaria, periorbital edema & circumoral edema;breath sounds clear & equal bilat;given DPH;
This case was reported by a healthcare professional and described the occurrence of seizure in a 6-month-old male subject who was vaccinated with Pediarix for prophylaxis. Previous and/or concurrent vaccination included Haemophilus influenzae type b vaccine given on 19 December 2006; influenza vaccine given on 19 December 2006; influenza virus vaccine given on 19 December 2006; pneumococcal vaccine given on 19 December 2006. On 19 December 2006 at 10:30 the subject received 3rd dose of Pediarix (.5 ml, unknown). On 19 December 2006, 3 hours after vaccination with Pediarix, the subject experienced "continual" seizure and problem breathing. The subject was hospitalised for 3 days and the healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). At the time of reporting the events were resolved. The reporter stated that even though the subject received additional vaccines that day, it was thought that Pediarix was the cause of the adverse events. Follow up information received on 19 January 2007 indicated that the reporter felt that the events were not related to treatment with Pediarix. The events remained resolved and were not considered at the time of follow-up to be severely or permanently disabling.
CT scan (head) Neurological consult/care EEG MRI. brain Fluoroscopy guided lumbar puncture patient presented to ED with altered LOC, seizures one day after vaccine.
Very painful, 50 cent piece-sized, red, itchy, raised welt. Gradually decreased in size; current non-tender pea sized hard lump.
received expired dose; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 63-year-old male patient who received HAB (Twinrix) (batch number 75C72, expiry date 13th June 2022) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 15th June 2022, the patient received Twinrix and Twinrix Pre-Filled Syringe Device. On 15th June 2022, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 15-June-2022 Reporter's comment: Nurse reported that the patient received a 2 days expired dose of twinrix. The reporter consented to follow up. Additional Supportive Information: The patient received expired twinrix which led to expired vaccine used.
Narrative: Pt is a 76 YO male with PMH of afib, CHF, HTN, and HLD. Pt's death was reported to facility by administration.
Recurrent mild dizziness, mild, short periods, sometimes occasional mild headache. Dizziness is daily since vaccine was given.  Seen by PCP on 2/17/21, diagnosed with vertigo,  Exercises given, and dizziness is less.
Itchy knot at the injection site that started a week after receiving the vaccine. It lasted a few days and then went away, leaving discoloration on the skin.
arm is red; swollen; hurts; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm is red), PERIPHERAL SWELLING (swollen) and PAIN (hurts) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (arm is red), PERIPHERAL SWELLING (swollen) and PAIN (hurts). At the time of the report, ERYTHEMA (arm is red), PERIPHERAL SWELLING (swollen) and PAIN (hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs were reported. No treatment drugs are not provided by reporter.
This spontaneous report was received from a healthcare worker and refers to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On an unspecified date, the patient was vaccinated with a dose of improperly stored GARDASIL 9 injection (lot # L037554, expiration date: 25-DEC-2017; dose and route of administration were not reported). No adverse effects were reported. It was stated that vaccination with GARDASIL 9 was not discontinued. There was no product quality complaint (PQC) involved. This is one of the several reports received from the same reporter. Additional information has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient was prescribed the ZOSTAVAX by a healthcare provider for the long-term prevention of shingles and zoster-related conditions. On or about 19-JAN-2010, the patient was administered the ZOSTAVAX by a health care provider (lot number, dosage and route of administration not provided). On an unknown date, the patient was treated by a health care provider for the following injury resulting from her use of ZOSTAVAX: shingles. The patient claims damages as a result of: injury to herself, loss of consortium, loss of services, and economic losses. The outcome of the shingles is unknown. Additional information has been requested.
Patient experienced signs and symptoms of vasovagal syncope. She was treated with an ice pack to the back of the head and O2. The patient recovered and complained of pain to the posterior of her head.
had a very dry mouth; some swelled and itchy hives on the back of my legs; some swelled and itchy hives on the back of my legs; some swelled and itchy hives on the back of my legs; chills; I was getting sick; hot; clammy; This is a spontaneous report from a contactable consumer (Patient). A 47-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: 6n6199 and Expiration date was not reported), via an unspecified route of administration, administered in Arm Left on 01Mar2021 15:45, as single dose for COVID-19 immunization. Patient's medical history included asthma, pneumonia, tuberculosis, whooping Cough and allergy to milk. Concomitant medications include Zyrtec, Magnesium, Calcium all taken for unspecified indications. The patient previously took vaccine for Pneumonia via an unspecified route of administration, administered in left arm, vaccine for tuberculosis and whooping cough via an unspecified route of administration, administered in right arm on 18Feb2021. The patient did not had COVID prior vaccination and was not COVID tested post vaccination. On 01Mar2021 08:00 pm, the patient started experiencing some swelled and itchy hives on back of legs, had very dry mouth since getting it (it's been 5 days). On an unknown date in Mar2021, the patient also began to feel like she was getting sick (but 5 days afterward), began to have chills, then hot and clammy. Therapeutic measures were taken as a result of chills, hot and clammy and patient was treated with Tylenol. The outcome of the events was reported as not resolved.  No follow-up attempts are possible. No further information is expected.
eyes went "buggery", felt like drunken eyes; feels tired; her eyes made her feel like she was going to throw up; arm is a little sore; 2 hives in each corner of mouth; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (eyes went "buggery", felt like drunken eyes), FATIGUE (feels tired), NAUSEA (her eyes made her feel like she was going to throw up), PAIN IN EXTREMITY (arm is a little sore) and URTICARIA (2 hives in each corner of mouth) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019d21a) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (Allergic to latex, penicillin, Novocain, codeine, and Neurontin.). Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), CARBAMAZEPINE (TEGRETOL) and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication, ACETYLSALICYLIC ACID, CARISOPRODOL (SOMA CMPD).    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced EYE SWELLING (eyes went "buggery", felt like drunken eyes), FATIGUE (feels tired), NAUSEA (her eyes made her feel like she was going to throw up), PAIN IN EXTREMITY (arm is a little sore) and URTICARIA (2 hives in each corner of mouth). On 01-Apr-2021, EYE SWELLING (eyes went "buggery", felt like drunken eyes) and NAUSEA (her eyes made her feel like she was going to throw up) had resolved. At the time of the report, FATIGUE (feels tired), PAIN IN EXTREMITY (arm is a little sore) and URTICARIA (2 hives in each corner of mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Patient suffered severe diarrhea and blood sugar level 27 mg/dL. Patient required overnight hospitalizations.
Didn't feel much discomfort; Like someone punched in the arm/it hurts to raise the arm/hurts more than the first two; Shoulder is more sore muscularly; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Didn't feel much discomfort), PAIN IN EXTREMITY (Like someone punched in the arm/it hurts to raise the arm/hurts more than the first two) and MYALGIA (Shoulder is more sore muscularly) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031H21A and 031L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL + HIDROCLOROTIAZIDA), AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), FLUOXETINE and PRAVASTATIN for an unknown indication.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (Didn't feel much discomfort), PAIN IN EXTREMITY (Like someone punched in the arm/it hurts to raise the arm/hurts more than the first two) and MYALGIA (Shoulder is more sore muscularly). At the time of the report, DISCOMFORT (Didn't feel much discomfort), PAIN IN EXTREMITY (Like someone punched in the arm/it hurts to raise the arm/hurts more than the first two) and MYALGIA (Shoulder is more sore muscularly) outcome was unknown.            No treatment medication information provided.  Patient's shoulder was more sore muscularly speaking compared to the first two. This started about an hour ago (now is around 19:50 EST) and the booster shot was given at 1.30 pm. Patient said it felt like someone punched in the arm like a bruise. It hurts when patient wants to raise the arm and it hurts more than with the first two. Patient will put on some ice pack to see if it alleviates the pain. Patient said that for the first two shots didn't feel much discomfort.   This case was linked to MOD-2021-396351, MOD-2021-396352 (Patient Link).